Gemina Laboratories (XCNQ:GLAB) Accounts Payable & Accrued Expense : C$2.56 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Accounts Payable & Accrued Expense?

Gemina Laboratories's quarterly accounts payable & accrued expense increased from Jul. 2023 (C$1.43 Mil) to Oct. 2023 (C$1.85 Mil) and increased from Oct. 2023 (C$1.85 Mil) to Jan. 2024 (C$2.56 Mil).

Gemina Laboratories's annual accounts payable & accrued expense increased from Jan. 2022 (C$0.43 Mil) to Jan. 2023 (C$1.71 Mil) and increased from Jan. 2023 (C$1.71 Mil) to Jan. 2024 (C$2.56 Mil).

Gemina Laboratories Accounts Payable & Accrued Expense Historical Data

The historical data trend for Gemina Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Accounts Payable & Accrued Expense Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Accounts Payable & Accrued Expense

0.12

0.43

1.71

2.56

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial							1.71	1.19	1.43	1.85	2.56

Gemina Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

GLABF:USA

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Executives

James Damian Tansey

Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines